Department of the Navy, DoD.
The Department of the Navy hereby gives notice of its intent to grant to LumaCyte, LLC a revocable, nonassignable, exclusive license to practice in the field of use of biomedical research and medical diagnostics in the United States, the Government-owned inventions described in U.S. Patent No. 8,529,760: Optical Separator and Method for Separating Particles Suspended in a Fluid, Navy Case No. 084,517.//U.S. Patent Application No. 13/954,654: Device and Method for Laser Analysis and Separation (LAS) of Particles, Navy Case No. 101,970.//U.S. Patent Application No. 13/961,968: Separation of Colloidal Suspensions Using Laser Optical Pressure Fluidic Devices, Navy Case No. 084,517.//U.S. Patent Application No. 14/043,384: Paired Laser and Electrokinetic Separation, Manipulation, and Analysis Device, Navy Case No. 102,097 and any continuations, divisionals or re-issues thereof.
Anyone wishing to object to the grant of this license must file written objections along with supporting evidence, if any, not later than February 18, 2014.
Written objections are to be filed with the Naval Research Laboratory, Code 1004, 4555 Overlook Avenue SW, Washington, DC 20375-5320.
Start Further Info
FOR FURTHER INFORMATION CONTACT:
Rita Manak, Head, Technology Transfer Office, NRL Code 1004, 4555 Overlook Avenue SW, Washington, DC 20375-5320, telephone 202-767-3083. Due to U.S. Postal delays, please fax 202-404-7920, email: email@example.com or use courier delivery to expedite response.
End Further Info
Dated: January 24, 2014.
N. A. Hagerty-Ford,
Commander, Office of the Judge Advocate General, U.S. Navy, Federal Register Liaison Officer.
[FR Doc. 2014-01918 Filed 1-30-14; 8:45 am]
BILLING CODE 3810-FF-P